What does Taysha Gene Therapies, Inc. (TSHA) do?

Taysha Gene Therapies, Inc. (TSHA) is a publicly traded company.

What sector does TSHA operate in?

Taysha Gene Therapies, Inc. operates in the equity market. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find research and analysis for TSHA?

AlphaOS provides AI-assisted research, earnings transcripts, SEC filing analysis, opportunity scoring, and knowledge-graph relationships for Taysha Gene Therapies, Inc. (TSHA). All content is for research and education — not investment advice.

Taysha Gene Therapies, Inc. (TSHA)

US equity research on AlphaOS

Taysha Gene Therapies, Inc. operates in unknown sector.

Taysha Gene Therapies, Inc. key market context on AlphaOS includes Market capitalization: $1.84B; Recent price: $6.40. Figures update as market data and SEC filings are ingested.

Use this TSHA research hub for earnings transcripts, SEC filings, opportunity scoring, news, and knowledge-graph relationships. Content is for research and education only — not investment advice.

Key facts

Market cap:: $1.84B
Revenue:: $9.77M

Interactive charts, filings, and live quotes load below. Research & analysis only — not investment advice.

TSHA

Taysha Gene Therapies, Inc.

$6.40Jun 18, 2026

AI confidence 62% · prior close shown (market closed)

Filing insights

Loading SEC filing intelligence…

SEC filings

10-K, 10-Q, 8-K, 20-F, 6-K from EDGAR — HTML & PDF stored in GCS

No filings yet

Ingest recent SEC filings for TSHA to enable RAG search and AI risk analysis.

Opening stock page...

Fetching company snapshot, pricing, and intelligence.